company background image
SUS logo

Surgical Science Sweden OM:SUS 株式レポート

最終価格

SEK 146.10

時価総額

SEK 7.2b

7D

5.5%

1Y

-11.7%

更新

21 Nov, 2024

データ

会社財務 +

Surgical Science Sweden AB (publ)

OM:SUS 株式レポート

時価総額:SEK 7.2b

SUS 株式概要

Surgical Science Sweden AB (publish)は、エビデンスに基づいた医療トレーニング用のバーチャルリアリティシミュレーターを、ヨーロッパ、北米、南米、アジア、そして国際的に開発・販売している。 詳細

SUS ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長4/6
過去の実績2/6
財務の健全性6/6
配当金0/6

Surgical Science Sweden AB (publ) 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめSurgical Science Sweden
過去の株価
現在の株価SEK 146.10
52週高値SEK 196.90
52週安値SEK 111.80
ベータ0.97
11ヶ月の変化16.14%
3ヶ月変化12.82%
1年変化-11.72%
33年間の変化-50.64%
5年間の変化90.23%
IPOからの変化1,170.43%

最新ニュース

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Nov 12
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Recent updates

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Nov 12
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jul 05
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Jun 08
Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Mar 23
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Mar 02
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Feb 09
Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

Jan 01
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Dec 14
What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Nov 26
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

株主還元

SUSSE Medical EquipmentSE 市場
7D5.5%-4.1%-2.1%
1Y-11.7%-9.7%10.8%

業界別リターン: SUS過去 1 年間で-9.7 % の収益を上げたSwedish Medical Equipment業界を下回りました。

リターン対市場: SUSは、過去 1 年間で10.8 % のリターンを上げたSwedish市場を下回りました。

価格変動

Is SUS's price volatile compared to industry and market?
SUS volatility
SUS Average Weekly Movement6.9%
Medical Equipment Industry Average Movement7.5%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.2%
10% least volatile stocks in SE Market3.3%

安定した株価: SUS過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: SUSの 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1997265Tom Englundwww.surgicalscience.com

Surgical Science Sweden AB (publish)は、エビデンスに基づいた医療トレーニング用のバーチャルリアリティシミュレーターをヨーロッパ、北米、南米、アジア、そして国際的に開発・販売している。血管内治療トレーニング用シミュレータAngio Mentor、BRONCH mentorシミュレータのポータブル版BRONCH Express、関節鏡手術スキル習得用ARTHRO Mentor、気管支鏡トレーニング最適化用シミュレータBRONCH Mentor、消化器内視鏡用シミュレータGI Mentor、True-To-Life診断・治療子宮鏡トレーニング用HYST Mentor;内視鏡トレーニング用バーチャルリアリティシミュレータURO Mentor、リアルなスコープシミュレータEndoSim、ロボット手術の基本および高度なスキルを教育するために設計された、柔軟でポータブルなトレーニングプラットフォームFlexVR、LAP Mentorは、幅広い腹腔鏡トレーニングケースを提供します。また、LapSim Hapticシミュレータで構成されるLapSimトレーニングシステムは腹腔鏡トレーニングを提供し、LapSim essenceはポータブルですぐに使えるVRシミュレータ、LapSim 360は没入感の高いバーチャルリアリティトレーニング体験を提供する。さらに、PELVIC Mentorシミュレータは解剖学と骨盤検査のトレーニングを提供し、Perc Mentorスイートは画像誘導インターベンションのために、RobotiX Mentorは外科医のための運動と認知スキルの練習のために、Simball Boxはデジタル収集されたメトリックを強力なトレーニングツールに組み合わせる;Spine Mentor:最小侵襲脊椎手術用トレーニングシミュレータ、TEE Express:TEEプローブを使用した経食道心エコー手技の教育用、TraumaVR:マネキンとVRシミュレーションの究極のミックス、Ultrasound Mentor:複数の医療専門分野での超音波トレーニング用。Surgical Science ABは1997年に設立され、スウェーデンのヨーテボリに本社を置いている。

Surgical Science Sweden AB (publ) 基礎のまとめ

Surgical Science Sweden の収益と売上を時価総額と比較するとどうか。
SUS 基礎統計学
時価総額SEK 7.25b
収益(TTM)SEK 193.34m
売上高(TTM)SEK 859.83m

38.6x

PER(株価収益率

8.7x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
SUS 損益計算書(TTM)
収益SEK 859.83m
売上原価SEK 269.58m
売上総利益SEK 590.25m
その他の費用SEK 396.91m
収益SEK 193.34m

直近の収益報告

Sep 30, 2024

次回決算日

Feb 19, 2025

一株当たり利益(EPS)3.79
グロス・マージン68.65%
純利益率22.49%
有利子負債/自己資本比率0%

SUS の長期的なパフォーマンスは?

過去の実績と比較を見る